Beijing Balance Medical Technology Co.,Ltd. (688198.SH): Radiofrequency Ablation System Enters Innovative Medical Device Special Review Process

Beijing Balance Medical Technology Co.,Ltd. (688198.SH) announced that its independently developed radiofrequency ablation system has received approval from the Center for Medical Device Evaluation under the National Medical Products Administration to enter the innovative medical device special review process.

The radiofrequency ablation system comprises three components: an ablation instrument, ablation clamp, and ablation pen, specifically designed for cardiac surgical treatment of persistent and permanent atrial fibrillation. Based on traditional maze surgery principles, the product employs direct-vision cardiac surgical approaches to achieve electrical isolation of atrial tissue by creating transmural, continuous, and irreversible linear lesions. This process eliminates atrial fibrillation trigger points and maintains the substrate, ultimately restoring normal sinus rhythm.